Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
Jain
Sandeep
S
Kapoor
Gauri
G
D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D002675:Child, Preschool; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009091:Mucormycosis / Q000150:complications / Q000188:drug therapy*; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy*; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects*; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects*
D000935:Antifungal Agents; D000972:Antineoplastic Agents, Phytogenic; D014230:Triazoles; D014750:Vincristine; C101425:posaconazole